Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Long Island Pharmaceuticals LLC
WARNING LETTER
•Long Island Pharmaceuticals LLC•July 3, 2014

Long Island Pharmaceuticals LLC – FDA Warning Letter, Jul 3, 2014

Record Details

The FDA inspected Long Island Pharmaceuticals, LLC's dietary supplement manufacturing facility from June 27 to July 3, 2014, finding serious violations of Current Good Manufacturing Practice (CGMP) regulations (21 CFR Part 111), rendering products adulterated under Section 402(g)(1) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. **Failure to verify identity of dietary ingredients (21 CFR 111.75(a)(1)(i))**: The firm did not verify the identity of numerous dietary ingredients in products like (b)(4) and (b)(4). The firm's proposed random identity testing and rotating assay testing were deemed inadequate, as all dietary ingredients must be verified. 2. **Failure to verify finished product specifications (21 CFR 111.75(c))**: The firm did not test finished batches for identity, purity, strength, and composition, stating customers were responsible. Their plan to assay one active ingredient and conduct microbiological testing was deemed insufficient without further justification. 3. **Failure to implement quality control operations (21 CFR 111.65)**: The firm lacked overall quality control operations and responsibilities. 4. **Improper equipment maintenance (21 CFR 111.27(a)(3)(v))**: Equipment, specifically a (b)(

Company
Long Island Pharmaceuticals LLC
Inspection date
July 3, 2014
Product type
Food
Office
New York District Office
Person
  • Ronald M. Pace (Program Director)
View Company Profile

ID · 34b19906-a860-415f-beed-97321c4a5d66

Violation Codes10
21 CFR 11121 U.S.C. 342(g)(1)21 CFR 111.75(a)(1)(i)21 CFR 111.75(a)(1)(ii)21 CFR 111.75(c)21 CFR 111.6521 CFR 111.27(a)(3)(v)21 CFR 111.27(d)21 CFR 111.8021 CFR 111.83

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Long Island Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.